Yan Wang

机构：Fujian Medical University, Harbin Medical University, Dalian Medical University, Dalian University, Mianyang Central Hospital, Shanghai University of Traditional Chinese Medicine, Third Affiliated Hospital of Harbin Medical University, Mengchao Hepatobiliary Hospital, First Affiliated Hospital of Fujian Medical University, Hebei University of Chinese Medicine, Shuguang Hospital, First Affiliated Hospital of Zhengzhou University, Southwest Jiaotong University, Chengdu University of Traditional Chinese Medicine · ORCID：0000-0002-1210-0258

发表论文 40 篇 · 总被引 616 次 · h-index 13

代表论文

• Using Network Pharmacology and Molecular Docking to Explore the Mechanism of Shan Ci Gu (Cremastra appendiculata) Against Non-Small Cell Lung Cancer (2021 · Frontiers in Chemistry · 被引 64)
• Corrigendum: β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-Pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial–Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling (2020 · Frontiers in Pharmacology · 被引 46)
• SHR6390 Combined with Cabozantinib Inhibits Tumor Progression in theHepatocellular Carcinoma Mouse Model (2022 · Current Gene Therapy · 被引 33)
• Role of Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) in Immune and Inflammatory Diseases (2023 · Inflammation · 被引 29)
• Insights into the Interaction Mechanisms of the Proviral Integration Site of Moloney Murine Leukemia Virus (Pim) Kinases with Pan-Pim Inhibitors PIM447 and AZD1208: A Molecular Dynamics Simulation and MM/GBSA Calculation Study (2019 · International Journal of Molecular Sciences · 被引 25)
• Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer (2019 · World Journal of Gastroenterology · 被引 25)